Why XPeng Shares Are Falling Today
XPEV shares are trading lower by 4% today after the Bernstein analyst downgraded the stock.
Bernstein analyst Eunice Lee downgraded XPeng Inc (NYSE: XPEV) from Outperform to Market Perform and lowered the price target from $16 to $12.
Lee expects XPeng to face pressure from growing competition and therefore lowered sales volume outlook for P7/P7i, G9, G3i, and P5 models.
Sales momentum could increase from Q3 with new launches, but concerns loom over the success of G6 following the disappointing acceptances of P5 and G9.
The RMB200-300k SUV also faced tough competition from Tesla Inc (NASDAQ: TSLA) and BYD Co, Ltd (OTC: BYDDF) (OTC: BYDDY).
The ongoing EV price war also pressurized the margins as XPeng has limited pricing power. Lee projected negative vehicle margins for Q1 as XPeng offered discounts following Tesla's move.
The analyst highlighted XPeng's organizational restructuring and cost-cut initiatives likely to improve margins by ten bps. However, the margin expansion is not likely before late 2023 or 2024.
Though XPeng revamps its marketing system, Lee finds monetization tricky.
XPeng's cash position serves as a confidence boost alleviating concerns about the company going out of business.
XPeng must demonstrate the pathway to positive cash flow and profit. Lee pushes out breakeven to 2026.
Price Action: XPEV shares are trading lower by 4.29% at $9.49 on the last check Friday.
Latest Ratings for XPEV
Date | Firm | Action | From | To |
---|---|---|---|---|
Feb 2022 | Barclays | Initiates Coverage On | Overweight | |
Jan 2022 | Macquarie | Initiates Coverage On | Outperform | |
Nov 2021 | B of A Securities | Maintains | Buy |
View More Analyst Ratings for XPEV
View the Latest Analyst Ratings
Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.
This article Why XPeng Shares Are Falling Today originally appeared on Benzinga.com
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.